The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Ralph Theo Schermuly

University of Giessen Lung Center

Giessen

Germany

[email]@*.med.uni-giessen.de

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • University of Giessen Lung Center, Giessen, Germany. 2011
  • University of Giessen Lung Center, Medical Clinic II/V, Justus-Liebig-University Giessen, 35392 Giessen, Germany. 2001 - 2007

References

  1. Therapeutic efficacy of TBC3711 in monocrotaline-induced pulmonary hypertension. Kosanovic, D., Kojonazarov, B., Luitel, H., Dahal, B.K., Sydykov, A., Cornitescu, T., Janssen, W., Brandes, R.P., Davie, N., Ghofrani, H.A., Weissmann, N., Grimminger, F., Seeger, W., Schermuly, R.T. Respir. Res. (2011) [Pubmed]
  2. Involvement of mast cells in monocrotaline-induced pulmonary hypertension in rats. Dahal, B.K., Kosanovic, D., Kaulen, C., Cornitescu, T., Savai, R., Hoffmann, J., Reiss, I., Ghofrani, H.A., Weissmann, N., Kuebler, W.M., Seeger, W., Grimminger, F., Schermuly, R.T. Respir. Res. (2011) [Pubmed]
  3. Iloprost-induced desensitization of the prostacyclin receptor in isolated rabbit lungs. Schermuly, R.T., Pullamsetti, S.S., Breitenbach, S.C., Weissmann, N., Ghofrani, H.A., Grimminger, F., Nilius, S.M., Schrör, K., Kirchrath, J.M., Seeger, W., Rose, F. Respir. Res. (2007) [Pubmed]
  4. Inhaled iloprost reverses vascular remodeling in chronic experimental pulmonary hypertension. Schermuly, R.T., Yilmaz, H., Ghofrani, H.A., Woyda, K., Pullamsetti, S., Schulz, A., Gessler, T., Dumitrascu, R., Weissmann, N., Grimminger, F., Seeger, W. Am. J. Respir. Crit. Care Med. (2005) [Pubmed]
  5. Lung vasodilatory response to inhaled iloprost in experimental pulmonary hypertension: amplification by different type phosphodiesterase inhibitors. Schermuly, R.T., Inholte, C., Ghofrani, H.A., Gall, H., Weissmann, N., Weidenbach, A., Seeger, W., Grimminger, F. Respir. Res. (2005) [Pubmed]
  6. Reversal of experimental pulmonary hypertension by PDGF inhibition. Schermuly, R.T., Dony, E., Ghofrani, H.A., Pullamsetti, S., Savai, R., Roth, M., Sydykov, A., Lai, Y.J., Weissmann, N., Seeger, W., Grimminger, F. J. Clin. Invest. (2005) [Pubmed]
  7. Chronic sildenafil treatment inhibits monocrotaline-induced pulmonary hypertension in rats. Schermuly, R.T., Kreisselmeier, K.P., Ghofrani, H.A., Yilmaz, H., Butrous, G., Ermert, L., Ermert, M., Weissmann, N., Rose, F., Guenther, A., Walmrath, D., Seeger, W., Grimminger, F. Am. J. Respir. Crit. Care Med. (2004) [Pubmed]
  8. Antiremodeling effects of iloprost and the dual-selective phosphodiesterase 3/4 inhibitor tolafentrine in chronic experimental pulmonary hypertension. Schermuly, R.T., Kreisselmeier, K.P., Ghofrani, H.A., Samidurai, A., Pullamsetti, S., Weissmann, N., Schudt, C., Ermert, L., Seeger, W., Grimminger, F. Circ. Res. (2004) [Pubmed]
  9. Zardaverine and aerosolised iloprost in a model of acute respiratory failure. Schermuly, R.T., Leuchte, H., Ghofrani, H.A., Weissmann, N., Rose, F., Kohstall, M., Olschewski, H., Schudt, C., Grimminger, F., Seeger, W., Walmrath, D. Eur. Respir. J. (2003) [Pubmed]
  10. Pharmacokinetics and metabolism of infused versus inhaled iloprost in isolated rabbit lungs. Schermuly, R.T., Schulz, A., Ghofrani, H.A., Meidow, A., Rose, F., Roehl, A., Weissmann, N., Hildebrand, M., Kurz, J., Grimminger, F., Walmrath, D., Seeger, W. J. Pharmacol. Exp. Ther. (2002) [Pubmed]
  11. Conebulization of surfactant and urokinase restores gas exchange in perfused lungs with alveolar fibrin formation. Schermuly, R.T., Günther, A., Ermert, M., Ermert, L., Ghofrani, H.A., Weissmann, N., Grimminger, F., Seeger, W., Walmrath, D. Am. J. Physiol. Lung Cell Mol. Physiol. (2001) [Pubmed]
  12. Urodilatin, a natriuretic peptide stimulating particulate guanylate cyclase, and the phosphodiesterase 5 inhibitor dipyridamole attenuate experimental pulmonary hypertension: synergism upon coapplication. Schermuly, R.T., Weissmann, N., Enke, B., Ghofrani, H.A., Forssmann, W.G., Grimminger, F., Seeger, W., Walmrath, D. Am. J. Respir. Cell Mol. Biol. (2001) [Pubmed]
  13. Combination of nonspecific PDE inhibitors with inhaled prostacyclin in experimental pulmonary hypertension. Schermuly, R.T., Roehl, A., Weissmann, N., Ghofrani, H.A., Leuchte, H., Grimminger, F., Seeger, W., Walmrath, D. Am. J. Physiol. Lung Cell Mol. Physiol. (2001) [Pubmed]
  14. Coaerosolization of phosphodiesterase inhibitors markedly enhances the pulmonary vasodilatory response to inhaled iloprost in experimental pulmonary hypertension. Maintenance of lung selectivity. Schermuly, R.T., Krupnik, E., Tenor, H., Schudt, C., Weissmann, N., Rose, F., Grimminger, F., Seeger, W., Walmrath, D., Ghofrani, H.A. Am. J. Respir. Crit. Care Med. (2001) [Pubmed]
 
WikiGenes - Universities